this may have already been discussed.
when looking at potential markets it may be useful to also consider, in the long run, the total numbers of mCRC confined to the liver, not simply the non resectable ones alone.
given that resection (surgery) comes with risks/pain/complications etc then IF Sirflox produces similar outcomes to resection, or even not much worse, then more patients/doctors (perhaps not surgeons) might choose Sirflox over surgery.
quality of life as well as quantum of life.
this may have already been discussed. when looking at potential...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $55.17M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $122.1K | 909.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 698620 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 797342 | 14 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| SRX (ASX) Chart |